10 results about "Calcium deficiencies" patented technology

The invention belongs to the technical field of gas chromatography detection, and relates to a gas chromatography method for simultaneously determining the content of ethanol and isopropyl myristate. The set conditions of the gas chromatography are as follows: the temperature of an FID detector and a polyethylene glycol 20M capillary column is 240-260 DEG C, the temperature of the detector is 240-260 DEG C, the carrier gas is nitrogen, the flow rate is 0.9-2.5 mL / min, the sample injection amount is 1 mu L, the column temperature is increased by adopting a program, the initial temperature is 80-90 DEG C, the temperature is increased to 180-190 DEG C at the rate of 9-12 DEG C / min, and the temperature is maintained for at least 10 minutes. The method provided by the invention can realize simultaneous detection of ethanol and isopropyl myristate, after the two substances are dissolved by the N, N-dimethylformamide solvent, the detected spectrogram does not have the phenomena of peak overlapping, trailing and the like, and the method has the advantages of high separation efficiency, high selectivity, high sensitivity, high analysis speed and wide application range.

Composition comprising a combination of oleuropein or metabolite thereof and taurine or functional derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and / or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.

The invention relates to a colla corii asini-oyster powder compound as well as a preparation method and application thereof, and belongs to the technical field of medicines and health-care products. The colla corii asini-oyster powder compound provided by the invention comprises the following components in parts by weight: a) 38-42 parts of colla corii asini; b) 15-25 parts of oyster powder; and c) 1-5 parts of an auxiliary material, wherein the auxiliary material is selected from one or more of polyvinylpyrrolidone, copovidone, hydroxy propyl cellulose and hydroxyethyl cellulose. The donkey-hide gelatin and oyster powder compound is prepared by using a hot-melt extrusion technology, so that the properties such as smell, wettability and dispersity of donkey-hide gelatin are obviously improved, and the donkey-hide gelatin has a good effect in an osteoporosis rat model and a mouse calcium deficiency model. The preparation process is simple and controllable, and has a good market prospect.

Disclosed herein are micro-sized aragonite compositions and methods for enhancing calcium uptake and overall plant health. The disclosure provides calcium compositions comprising particles of aragonite, preferably oolitic aragonite, that are mechanically reduced to micron or sub-micron dimensions to generate a highly bioavailable, rapidly dissolving calcium source suitable for foliar or soil application. The compositions may be incorporated into liquid suspensions, granules, coated fertilizers, seed treatments, or nutrient delivery systems, and may optionally include biologically active agents, growth stimulants, humates, or surfactants to further promote uptake. Methods of using the compositions to treat calcium deficiency, strengthen cell walls, reduce blossom-end rot, increase stress tolerance, and improve yield are also provided.

The invention relates to the pharmaceutical industry and can be used for creating a medicinal preparation or dietary supplement for the prophylaxis and treatment of calcium deficiency and osteoporosis. The essence of the invention consists in a composition for the prophylaxis and treatment of calcium deficiency and osteoporosis which contains tribasic calcium phosphate, magnesium hydroxide, cholecalciferol, pyridoxine hydrochloride, resveratrol, astragaloside IV, sodium selenate, zinc oxide and sodium borate. The technical result of the invention lies in more effective prophylaxis and treatment of calcium deficiency and osteoporosis, together with increased calcium absorption into bone tissue, as well as in a tailored medical effect which consists in preventing loss of bone mass in postmenopausal women with no obvious symptoms of osteoporosis.

Composition comprising a combination of oleuropein or metabolite thereof and fisetin or derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and / or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.

A composition is provided that includes a combination of oleuropein or a metabolite thereof and taurine or a functional derivative thereof. The composition may be an oral nutritional composition, such as a dietary supplement, an oral nutritional supplement, a food product, or a food for special medical purposes (FSMP). The composition can be administered to an individual in need thereof for (ii) improving a physiological condition associated with metabolic fatigue in one or more cells, (iii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iv) improving antioxidant capacity, reducing oxidative stress, and / or enhancing mitochondrial function, or (iv) treating or preventing calcium deficiency / depletion disorders in the individual. Additionally or alternatively, the method can be used to treat or prevent a mitochondrial-related disease or condition associated with altered mitochondrial function in an individual in need of or at risk for such disease or condition.

The invention belongs to the technical field of calcium supplement preparations, and particularly relates to a medicinal synanthrin chelated calcium preparation and preparation and application thereof in calcium deficiency diseases, the medicinal synanthrin chelated calcium preparation comprises synanthrin chelated calcium and microcapsules coating the synanthrin chelated calcium, and wall materials of the microcapsules comprise maltodextrin and gelatin; the synanthrin chelated calcium has carboxymethyl synanthrin macromolecules and calcium ions chelated with the macromolecules, carboxyl groups in the carboxymethyl synanthrin macromolecules are combined with the calcium ions through coordinate bonds, the molar ratio of the synanthrin macromolecules to the calcium ions is 1: (0.1-1.4), and the substitution degree of carboxymethyl is 0.20-2.80. The purity of the preparation is larger than or equal to 95%, the highest purity can reach 99.2%, the preparation can reach the medicinal level, the product stability is good, targeted absorption is promoted, the absorption rate is high, the preparation is suitable for efficient calcium supplement, and the preparation has the advantages of being high in absorption rate, small in gastrointestinal tract stimulation, having the prebiotics function and the like and is especially suitable for osteoporosis, rickets, climacteric syndromes and other calcium deficiency related diseases.

Composition comprising a combination of fisetin or derivative thereof and quercetin or derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and / or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.

This invention provides a traditional Chinese medicine composition for treating osteoporosis, including its calcium-supplementing and bone-strengthening properties, preparation method, and application. The composition comprises Dipsacus asper, oyster shell, Astragalus membranaceus, Angelica sinensis, Caesalpinia sappan, Curculigo orchioides, Drynaria fortunei, Eucommia ulmoides, Polygonum cuspidatum, and Glycyrrhiza uralensis. Through scientific and rational formulation and preparation methods, this traditional Chinese medicine composition exhibits the effects of invigorating qi and strengthening the spleen, tonifying the liver and kidneys, and supplementing calcium and strengthening bones, significantly improving the effectiveness of treating osteoporosis caused by calcium deficiency. Furthermore, this traditional Chinese medicine composition contains no toxic herbs, has few side effects, and is highly safe.